While Semaglutide revolutionized the market, the addition of the GIP receptor in Tirzepatide showed that multi-pathway targeting was more effective
Defendants proposed approach conflicts with Federal Rule of Evidence 702 and current clinical standards and has no place in this litigation
Meanwhile, the deal marks something of a change in tone from Hims & Hers, which has been aggressive in its efforts to promote compounded therapies
When shopping for L-arginine supplements, seek out products that have been third-party tested to ensure quality
Shares of Novo first fell after the Hims announcement on Thursday, but then recovered and Hims shares fell after the FDA announcement on Friday
For people with lupus, this added benefit could be an important consideration, particularly if they have other risk factors for heart disease